DTB is changing
Coming September 2018
Drug and Therapeutics Bulletin (DTB) was one of the UK’s first evidence-based medical publications and is committed to providing practical, independent evidence-based information. We’ve carried out extensive research amongst our community of healthcare professionals enabling us to reinvent DTB, with the ultimate aim of ensuring that the content we publish helps patients get the best care.
What you can expect from the new DTB:
- Transparency and openness: We will recognise the contribution of the original authors by publishing their names and conflict of interest statements
- Accessible content: With a new colour and enhanced layout, readers can quickly access key messages, patient specific information and take home learning points
- Critical commentary: We will strive to challenge issues and be the leader on advice for drugs and therapeutics that really matter to your practice
- Immediate publication: We will publish content online as soon as it’s ready, ensuring readers receive timely updates online
DTB will continue to adopt a rigorous peer review policy and adhere to the highest possible industry standards concerning publication ethics. DTB also remains completely unbiased and independent from the pharmaceutical industry, government and regulatory authorities, pharmaceutical advertising and other forms of commercial sponsorship.